Ultrasound Probe Disinfection Market

Ultrasound Probe Disinfection Market

The global ultrasound probe disinfection market is expected to grow from $501 million in 2023 to $936 million by 2030, at a CAGR of 13.3%. This growth is driven by the increasing awareness of the importance of high-level disinfection of ultrasound probes, the growing demand for low-cost ultrasonography procedures, and the development of new automated high-level disinfection systems.

Growing awareness of high-level disinfection of semi-critical probes and rising demand for low-cost ultrasonography procedures are driving market expansion. Infectious illnesses developed as a result of inappropriate ultrasound probe reprocessing necessitate high-level disinfection of endocavitary probes after usage or during surgery. Many major firms are working to expand their installed bases of automated high-level disinfection systems across the world. The high level of compliance with high-level disinfection criteria in developed markets is a primary driving force behind the deployment of automated high-level disinfection systems for critical and semi-critical ultrasound probes.

Ultrasound Probe Disinfection Market Dynamics

Driver: An increasing number of ultrasonic imaging procedures are being performed.

Advancements in ultrasound imaging have led to improved diagnosis and reduced healthcare costs.

• More precise diagnosis: Advances in diagnostic ultrasound imaging technology have enabled clinicians to gather more thorough and dependable information about a patient's health. This has led to more accurate diagnosis and treatment of a wide range of ailments.
• Lower healthcare costs: Because fast diagnostic data is so easy to utilise, total healthcare costs have been decreased by substituting more expensive diagnostic exams. Ultrasound imaging, for example, may be used to detect cardiac abnormalities, which can subsequently be utilised to prevent heart attacks and strokes. This might save the healthcare system millions of dollars each year.

The increasing geriatric population is another major factor driving the growth of the ultrasound probe disinfection market.

• Growing geriatric population: The world population is ageing, and the number of individuals over 65 is predicted to rise by 25% by 2050. This ageing population is more prone to chronic ailments including heart disease, cancer, and stroke. Ultrasound imaging is an important diagnostic and monitoring technique for many disorders.
• Rising demand for ultrasound imaging: Rising demand for ultrasound imaging is propelling the ultrasound probe disinfection market forward. To avoid the transmission of infection, ultrasound probes must be carefully cleaned after each usage. Automated disinfection systems are gaining popularity because they provide a more efficient and effective method of disinfecting ultrasonic probes.

The number of ultrasound imaging operations conducted on NHS patients grew from 9,446,855 in 2021 to 9,927,335 in 2022, according to the Diagnostic Imaging Dataset Statistical Release.

The NHS's requirement for ultrasound imaging is growing, according to these numbers. This growth is being driven by a number of factors, including an ageing population, an increase in the prevalence of chronic conditions, and the introduction of new ultrasonic imaging equipment.

Overall, the ultrasound probe disinfection market is expected to grow in the coming years. This growth is being driven by a number of factors, including the increasing use of ultrasound imaging, the aging population, and the development of new ultrasound imaging technologies.

Restraint: High cost of automated probe reprocessors

High-level disinfection (HLD) is essential for preventing the spread of infection through ultrasound probes, but it is often not possible in developing countries due to the high cost of automated reprocessors.

• Automated reprocessors can cost between $15,000 and $35,000, which is out of reach for many hospitals in developing countries.
• Manual reprocessing methods are less effective and can lead to the spread of infection.
• Probe covers are a cheaper alternative, but they are not as effective as automated reprocessors.
• There is a lack of awareness of the importance of HLD among radiologists and patients in developing countries.
• There are also no strict regulations in place to ensure that HLD is performed correctly.

As a result, people in impoverished nations are more likely to become infected by ultrasonic probes.

There are several options for dealing with this issue, including:

• Creating more cost-effective automated reprocessors.
• Increasing radiologists' and patients' understanding of the significance of HLD.
• Imposing tougher requirements to guarantee proper HLD performance.

Patients in underdeveloped nations will continue to be at risk of infection from ultrasonography probes until these procedures are implemented.

Opportunity: Rising birth rates and the number of pregnancies

The growing number of births and pregnancies throughout the world will push the usage of ultrasound technology in obstetrics and neonatal care. This, in turn, is projected to open up new potential for makers of ultrasonic probe disinfection products.

Here are some more specifics:

• The number of births is predicted to rise by 4% between 2022 and 2030.
• The number of preterm births is likely to rise as well.
• Ultrasound technology is being utilised more and more to diagnose foetal health issues.
• This necessitates the development of efficient ultrasonic probe disinfection solutions.
•  

Challenge: A lack of understanding regarding probe reprocessing

The decontamination of ultrasound probes is a critical step in the reprocessing process, as the use of infected probes can lead to serious patient illnesses or instrument failures. According to a survey by the Joint Commission, hospital-acquired infections (HAIs) caused by bacterial agents or blood-borne pathogens in patients are on the rise due to a lack of knowledge among healthcare providers about probe reprocessing.

High-level disinfection (HLD) after each use and reprocessing of an ultrasound probe is a complex task that requires trained personnel. As a result, many hospitals hire certified sterile processing teams. Written and up-to-date guidelines and procedures must be available on-site for training and monitoring of staff responsible for device reprocessing. The market is being hampered by a lack of knowledge about probe reprocessing and a lack of awareness of the importance of thorough cleaning of all transducers.

North America is estimated to account for the largest share of the ultrasound probe disinfection market by 2023.

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa account for the majority of the ultrasound probe disinfection market. In terms of market share, North America is expected to lead the ultrasound probe disinfection market in 2023. This might be due to an increase in hospital-acquired infections (HAIs) and the number of ultrasound imaging treatments performed in the area.

In terms of probe type, the linear transducers segment is expected to lead the Ultrasound Probe Disinfection Market in 2023.

The Ultrasound Probe Disinfection market is segmented into five regions based on location: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In 2023, North America is expected to dominate the ultrasound probe disinfection market in terms of market share. This can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and the increasing number of ultrasound imaging procedures performed in the region.

The hospitals and diagnostic imaging centres sector is expected to expand at the fastest CAGR throughout the projection period.

The ultrasound probe disinfection market is segmented by end user, which includes maternity centres, hospitals & diagnostic imaging centres, ambulatory care centres, research & academic institutes, and other end users. The hospitals and diagnostic imaging centres category is expected to develop at the fastest CAGR between 2023 and 2030. The growing need for high-level disinfection (HLD) of semi-critical and critical ultrasound probes due to the danger of HAIs and the increasing number of ultrasound imaging procedures is propelling the expansion of this market.

Major players in this market in the ultrasound probe disinfection market include Nanosonics (Australia), Tristelplc (UK), STERIS plc (US), Ecolab (US), Advanced Sterilization Products (US), Metrex Research, LLC. (US), CIVCO Medical Solutions (US), CS Medical LLC (US), Virox (Canada), Germitec (France), Schülke&Mayr GmbH (Germany), Parker Laboratories, Inc. (US).

The study categorizes the Ultrasound Probe Disinfection Market to forecast revenue and analyze trends in each of the following submarkets

By Product Type

• Instruments
  • Automated Reprocessors
  • Manual Reprocessors/ Soaking Stations
  • Ultrasound Transducer Storage Cabinets
• Consumables
  • Disinfectants
    • By Formulation
      • Disinfectant Wipes
      • Disinfectant Liquid
      • Disinfectant Sprays
    • By Type
      • High-Level Disinfectants
      • Low-Level Disinfectants
  • Detergents
    • Enzymatic
    • Non-Enzymatic

• Services

By process

• High-Level Disinfection
• Low-Level Disinfection

By Type of Probe

• Linear Transducers
• Convex Transducers
• Phased Array Transducers
• Endocavitary Transducers
• TEE Transducers
• Other Transducers

By End User

• Hospitals & Diagnostic Imaging Centers
• Ambulatory Care centers
• Maternity Centers
• Academic & Research Institutes
• Others

By Mode of Purchase

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of APAC
• Latin America
• Middle East & Africa

Recent Developments

• • TristelPlc will work with Parker Laboratories in September 2023. Parker will produce and distribute Tristel DUO, a disinfecting foam certified for the cleaning and disinfection of general medical surfaces, including ultrasound transducers, in the US markets as part of this agreement.
• • Metrex Research, LLC established a strategic relationship with the Association for Professionals in Infection Control and Epidemiology (APIC) in March 2021 to lower infection risk.
• • Cantel Medical Corporation, a significant leader in the infection control industry for endoscopy, dentistry, dialysis, and life sciences services, was bought by STERIS plc. in June 2021. This purchase enhanced STERIS's market share in infection prevention and ultrasound probe disinfection.

In February 2020, GAMA Healthcare Ltd. partnered with Cardiff University. The partnership helped GAMA Healthcare in the R&D of innovative disinfection solutions. GAMA Healthcare provided funding of USD 687,827.50 (GBP 500,000) to the University for procuring innovative solutions.